Trial
NCT04864392
Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Osteoarthritis
Intervention
LNA043
Why stopped
Study early terminated due to lack of effect (did not meet primary/ secondary endpoints). This decision was not linked to safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-02